BioSpace News Archive

Centogene N.V. today announced its conference schedule for March 2023.

Zomedica Corp. will host a conference call and audio-only webcast on Wednesday, March 15, at 4:30 p.m. ET to discuss the Company’s operational and financial highlights for its fourth quarter and fiscal year ended December 31, 2022.

Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) notified the companies that the agency does not currently plan to convene an advisory committee meeting to discuss the New Drug Application (NDA) for zuranolone in the treatment of major depressive disorder (MDD) and postpartum depression (PPD).

Merck is scheduled to participate in a fireside chat at the Barclays 2023 Global Healthcare Conference on Wednesday, March 15, 2023, at 2:35 p.m. ET.

Matinas BioPharma Holdings, Inc. announces that it will report 2022 financial results after market close on Wednesday, March 15, 2023.

Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral direct acting therapeutics for several viral diseases, today announced six upcoming presentations at the 36th International Conference on Antiviral Research (ICAR), which will take place March 13-17, 2023 in Lyon, France.

TScan Therapeutics, Inc. today reported financial results for the three months and full year ended December 31, 2022, and highlighted upcoming anticipated milestones.

Rezolute, Inc. will host a virtual event to highlight the Company’s RZ402 Phase 2 clinical program and the rationale for an oral plasma kallikrein inhibitor (PKI) in diabetic macular edema (DME) on Wednesday, March 22, 2023, from 4:30 p.m.

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced financial results for the fourth quarter and full year ended December 31, 2022.

REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences.